RhoVac
RhoVac
RhoVac® was a pharmaceutical company dedicated to immuno-oncology, signifying that the body’s own immune system is stimulated to identify and destroy cancer cells. The primary focus of RhoVac® is to develop a cancer therapy that targets metastatic cells to prevent cancer recurrence and progression after primary tumour therapy.
HEADQUARTER
RhoVac AB
Medicon Village, Scheeletorget 1, Lund, Sweden
WEBSITE
www.rhovac.com
Idogen
Idogen
Idogen develops tolerogenic cell therapies to counteract attacks by the patient’s immune system on biological agents, transplanted organs or the body’s own cells or tissue. The term ‘tolerogenic’ refers to the immune system’s selective tolerance of a specific pathogenic or immunostimulatory antigen following treatment with Idogen’s cell therapy. Idogen’s most advanced product candidate, IDO 8, is designed for patients with severe hemophilia A who have developed neutralizing antibodies against their life-saving therapy with coagulation factor VIII (FVIII).
HEADQUARTER
Idogen
Medicon Village, Scheelevägen 2, SE-223 81 Lund, Sweden
WEBSITE
https://idogen.com
Coegin Pharma
Coegin Pharma
Coegin Pharma is a Nordic biotech company that, with unique technologies and competencies, focuses on the development of new pioneering treatments for diseases with a great medical need and great commercial potential. Through portfolio companies, the company will identify and value attractive development projects in preclinical and early clinical studies with a clear potential to add value and exit early.
HEADQUARTER
Coegin Pharma
c/o Medicon Village
223 81 Lund, Sweden
WEBSITE
www.coeginpharma.com